Microbot Medical Inc. MBOT recently announced that it has entered into an agreement with Emory University, which is likely to allow the entities to evaluate and explore the potential for future collaboration in connection with autonomous robotics in endovascular procedures.

Autonomous robotics has the potential to standardize outcomes, improve efficiencies, reduce radiation exposure, and democratize access to top-level healthcare. The evaluation phase is likely to explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system.

Price Performance

For the past six months, MBOT’s shares have plunged 23.2% against the industry’s growth of 0.2%. The S&P 500 increased 8.3% in the same time frame.

Image Source: Zacks Investment Research

More on the News

Under the terms of the agreement, Emory University is likely to assume the responsibility of exploring the feasibility of integrating the LIBERTY Endovascular Robotic Surgical System with an imaging system to create an autonomous robotic system for endovascular procedures.

MBOT’s vision for the future of endovascular robotics includes autonomous capabilities, which have the potential to standardize endovascular procedures and improve access to benefit millions of patients globally. The company believes that its LIBERTY system can be integrated with imaging, planning and navigation software to ultimately create an autonomous robotic system that can be used in endovascular procedures.

MBOT also entered into a collaboration agreement with Corewell Health to enable telerobotics in remote centers by utilizing the LIBERTY Endovascular Robotic Surgical System.

More on the LIBERTY Endovascular Robotic Surgical System

Microbot Medical’s LIBERTY Robotic System is the world’s first single-use endovascular robotic system focused on increasing access to robotic technology and revolutionizing the way endovascular procedures are performed. The system eliminates the need for large, cumbersome and expensive capital equipment while reducing radiation exposure and physician strain.

The company believes the LIBERTY Endovascular Robotic Surgical System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.

In July, Microbot Medical announced that Baptist Hospital of Miami had completed its first clinical procedure in a patient utilizing the LIBERTY Endovascular Robotic Surgical System. Baptist Hospital of Miami is the second site to perform clinical procedures as part of MBOT’s pivotal human clinical trial. The first clinical case was performed at Boston, MA-based Brigham and Women’s Hospital.